BridgeBio Pharma Inc. (BBIO) Tops Q1 EPS by 72c
Tweet
Share
E-mailGet Alerts BBIO Hot Sheet
Join SI Premium – FREE
BridgeBio Pharma Inc. (NASDAQ: BBIO) reported Q1 EPS of ($0.20), $0.72 better than the analyst estimate of ($0.92).
For earnings history and earnings-related data on BridgeBio Pharma Inc. (BBIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Citi cuts Micron stock target, sees memory chip prices peaking in 2Q27
- Artiva Biotherapeutics, Inc. (ARTV) Misses Q2 EPS by 63c
- Evommune, Inc. (EVMN) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
